155 related articles for article (PubMed ID: 823106)
1. Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes.
Gruenewald R; Levine S
Infect Immun; 1976 Jun; 13(6):1613-8. PubMed ID: 823106
[TBL] [Abstract][Full Text] [Related]
2. Effect of tilorone treatment on intracellular microbial infections in specific-pathogen-free mice.
Collins FM
Antimicrob Agents Chemother; 1975 Apr; 7(4):447-52. PubMed ID: 125066
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cellular suppression induced by oral tilorone treatment of mice.
Collins FM
Infect Immun; 1980 Oct; 30(1):289-96. PubMed ID: 6777302
[TBL] [Abstract][Full Text] [Related]
4. Effect of interferon inducers and purified mouse interferon on the susceptibility of mice to infection with Listeria monocytogenes.
Grappel SF; Polansky MJ; Actor P
Adv Exp Med Biol; 1983; 162():227-33. PubMed ID: 6191531
[No Abstract] [Full Text] [Related]
5. Impaired macrophage functions as a possible basis of immunomodification by microbial agents, tilorone and dimethyldioctadecylammonium bromide.
Bloksma N; de Reuver MJ; Willers JM
Antonie Van Leeuwenhoek; 1983 Apr; 49(1):13-22. PubMed ID: 6351737
[TBL] [Abstract][Full Text] [Related]
6. Modulation of natural killer activity in mice following infection with Listeria monocytogenes.
Kearns RJ; Leu RW
Cell Immunol; 1984 Apr; 84(2):361-71. PubMed ID: 6423290
[TBL] [Abstract][Full Text] [Related]
7. Effects of Staphylococcus epidermidis on cellular immunity to infection with Listeria monocytogenes.
Ehlers S; Rodloff AC; Hahn H
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):200-12. PubMed ID: 3146842
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromide.
Antonissen AC; Lemmens PJ; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1986; 52(1):75-84. PubMed ID: 2425734
[TBL] [Abstract][Full Text] [Related]
9. Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes.
Mizuki M; Nakane A; Sekikawa K; Tagawa YI; Iwakura Y
Infect Immun; 2002 Sep; 70(9):4805-11. PubMed ID: 12183523
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the immune response to Listeria monocytogenes. I. Immune complexes inhibit resistance.
Virgin HW; Unanue ER
J Immunol; 1984 Jul; 133(1):104-9. PubMed ID: 6202779
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated resistance to infection with Listeria monocytogenes in nude mice.
Emmerling P; Finger H; Hof H
Infect Immun; 1977 Feb; 15(2):382-5. PubMed ID: 403135
[TBL] [Abstract][Full Text] [Related]
12. Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production.
North RJ
J Exp Med; 1973 Aug; 138(2):342-55. PubMed ID: 4198199
[TBL] [Abstract][Full Text] [Related]
13. Impairment of T cell-mediated immunity to Listeria monocytogenes in pregnant mice.
Sano M; Mitsuyama M; Watanabe Y; Nomoto K
Microbiol Immunol; 1986; 30(2):165-76. PubMed ID: 3086677
[TBL] [Abstract][Full Text] [Related]
14. A role for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes.
Messingham KA; Badovinac VP; Jabbari A; Harty JT
J Immunol; 2007 Aug; 179(4):2457-66. PubMed ID: 17675507
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity.
Miller MA; Skeen MJ; Ziegler HK
Ann N Y Acad Sci; 1996 Oct; 797():207-27. PubMed ID: 8993364
[TBL] [Abstract][Full Text] [Related]
16. Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.
Ray NB; Krieg AM
Infect Immun; 2003 Aug; 71(8):4398-404. PubMed ID: 12874318
[TBL] [Abstract][Full Text] [Related]
17. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.
D'Orazio SE; Halme DG; Ploegh HL; Starnbach MN
J Immunol; 2003 Jul; 171(1):291-8. PubMed ID: 12817010
[TBL] [Abstract][Full Text] [Related]
18. Listeria monocytogenes-induced gamma interferon secretion by intestinal intraepithelial gamma/delta T lymphocytes.
Yamamoto S; Russ F; Teixeira HC; Conradt P; Kaufmann SH
Infect Immun; 1993 May; 61(5):2154-61. PubMed ID: 8478105
[TBL] [Abstract][Full Text] [Related]
19. Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.
Haak-Frendscho M; Young KM; Czuprynski CJ
Infect Immun; 1989 Oct; 57(10):3014-21. PubMed ID: 2789191
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by a LLO-deficient Listeria monocytogenes.
Yin Y; Zhang C; Dong H; Niu Z; Pan Z; Huang J; Jiao X
Microbiol Immunol; 2010 Apr; 54(4):175-83. PubMed ID: 20377746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
